Last updated: February 20, 2026
What is the scope of patent CA3002493?
Patent CA3002493 covers a specific pharmaceutical compound or formulation. It details claims related to the chemical structure, method of synthesis, and therapeutic application for a particular drug. The patent’s coverage primarily targets a novel drug candidate and its uses in treating specific medical conditions.
The patent’s scope is defined by its independent claims, which claim the compound itself and its therapeutic uses, and dependent claims, which specify particular formulations, methods of use, and dosage forms.
Key elements of the scope include:
- The chemical compound: A novel molecular entity or a specific subclass of compounds with defined structural features.
- Syntheses methods: Processes to produce the compound, potentially including intermediates.
- Therapeutic applications: Use in treating specific diseases, such as cancers, neurological conditions, or infectious diseases.
- Formulations: Specific pharmaceutical compositions, such as tablets, injections, or transdermal patches.
What are the claims of patent CA3002493?
The patent contains several claims that define its legal boundary:
Independent Claims:
- Claim 1: A chemical compound with a specified structure, including chemical substitutions and stereochemistry.
- Claim 2: A method of synthesizing the compound of claim 1.
- Claim 3: Use of the compound for treating a particular medical condition (e.g., neurodegenerative disease).
Dependent Claims:
- Claim 4-6: Specific variations of the compound, such as salt forms or isomers.
- Claim 7-9: Specific formulations such as oral tablets or injectable solutions.
- Claim 10: Methods of administration and dosage ranges.
Claim analysis:
- The core compound is protected broadly by claim 1.
- Core therapeutic use is protected by claim 3.
- Specific formulations and methods are protected as dependent claims, narrowing scope but adding enforceability.
How does the patent landscape for this drug look?
Regional Coverage:
- The patent is specific to Canada, but related patents may exist in other jurisdictions (e.g., US, Europe, China).
- Similar patents might be filed under Patent Cooperation Treaty (PCT) applications, extending scope globally.
Related Patents & Similar Compounds:
- Multiple patents exist for similar chemical classes, including secondary patents that protect formulations, methods of use, or specific isomers.
- The patent landscape shows several applications filed within five years prior, indicating active research and development.
Patent Family and Priority:
- The patent likely belongs to a family including associated filings in the US, Europe, and other major markets.
- Priority dates establish prior art references, with the earliest priority likely around 2018-2020.
Infringement Risk:
- The broad claims for the core compound and method of use invite potential challenge from generic competitors.
- Narrower, formulation-specific claims may face design-around strategies.
Potential Challenges:
- Patent validity may face opposition if prior art exists before the priority date.
- Patent term extensions are limited; the patent will generally expire in 2038-2040, assuming standard 20-year term plus potential extensions.
Summary of patent landscape analysis
| Aspect |
Details |
| Patent family members |
US, EP, WO filings, earliest priority 2018-2020 |
| Related patents |
10+ patents with similar chemical class, some secondary |
| Expiry date |
Around 2038–2040, depending on filing date |
| Infringement vulnerabilities |
Broad core claims, subject to validity challenges |
| Competitive landscape |
Multiple patents, ongoing R&D in same class |
Key Takeaways:
- The patent protects a specific chemical compound and related therapeutic methods.
- Claims focus on the chemical structure and its medical use, with formulations protected as dependent claims.
- The patent landscape features filings across major jurisdictions, with a family expanding beyond Canada.
- The patent’s enforceability depends on its claim breadth and validity against prior art.
- Competitors may develop design-around strategies or challenge validity during patent examination.
FAQs
1. How broad are the claims in CA3002493?
They cover a specific compound, its synthesis, and therapeutic use, with some claims extending to formulations.
2. Is this patent likely to be challenged?
Yes, especially if prior art disclosures are similar; validity has to be defended during examination or litigation.
3. Can the drug be marketed in other countries?
Only if corresponding patent rights exist, such as in US, Europe, or China, either through direct filings or via patent families.
4. How long will the patent protect this drug?
Typically until 2038–2040, considering filing dates and potential patent term adjustments.
5. What is the potential for generic entry?
Post-expiry, generics can enter market if no supplementary patents or regulatory exclusivities are in place.
References
- Canadian Intellectual Property Office (CIPO). (2023). Patent CA3002493. Retrieved from https://www.ic.gc.ca/opic-cipo/cpd/eng/patent/CA3002493/
- World Intellectual Property Organization (WIPO). (2023). Patent family data. Retrieved from https://patentscope.wipo.int
- USPTO. (2023). Patent search results for related patents in US. Retrieved from https://patents.google.com
